POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (9.24.2021, 6:35pm CEST, WHO):   U.S. 121,396    India 31,382    Brazil 36,473    United Kingdom 35,764    Russia 21,379    Turkey 27,844    France 5,433    Argentina 2,034    Columbia 1,581    Spain 1,056    Italy 4,053    Indonesia 2,557    Germany 9,727    Mexico 11,603    South Africa 2,783    Philippines 17,411    Ukraine 9,058    Malaysia 13,754    Netherlands 1,841    Iraq 2,953    Japan 3,457    Canada 3,870    Bangladesh 1,233    Thailand 12,697    Israel 6,314    Pakistan 2,357    Romania 7,116    Serbia 6,480    Cuba 6,935    Nepal 1,103    Vietnam 9,472    Austria 1,708    Greece 2,101    Georgia 1,698    Belarus 1,973    Costa Rica 2,547    Bulgaria 1,835    Azerbaijan 1,178    Myanmar 1,667    Croatia 1,291    Ireland 1,354    Venezuela 1,140    Ethiopia 1,544    Libya 1,006    Lithuania 1,477    South Korea 2,434    Mongolia 2,612    Slovenia 1,011    Moldova 1,215    Botswana 2,639    New Caledonia 1,078    China 65    Singapore 1,504    New Zealand 10    Australia 1,850   

Sri Lankan expert says Sinopharm COVID vaccine ideal for children

Christian Fernsby |
China's Sinopharm vaccine is ideal for children as it is an inactivated vaccine, Sri Lankan virology expert Prof. Tissa Vitharana said.

Article continues below




Sri Lankan Prime Minister Mahinda Rajapaksa said in August that the government would soon begin vaccination of children over 12 years old. Local experts have been debating over the best vaccine to administer young children.

"We must first do a pilot project with a random sample encompassing different groups, after looking at the data. We should see if antibodies are formed and if there are any side effects. My opinion is based on the scientific method and I think Sinopharm is the best for children," Vitharana was quoted by local daily The Island as saying.

Vitharana is a graduate of the University of London and was head of the Medical Research Institute of Sri Lanka from 1983 to 1994.

Sri Lanka has so far fully vaccinated over 50 percent of its population. Vaccinations are currently open to all adults over the age of 18.


What to read next

WHO approves Sinopharm COVID-19 vaccine for emergency use
New vaccine to provide 2-year protection
WHO validates Sinovac COVID-19 vaccine for emergency use